ArticleJournal of translational medicine2026
Glibenclamide attenuates osteoarthritis by suppressing NLRP3 inflammasome activation in synovial macrophages through the MAPK pathway.
Jinrong Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.